HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Katrin Sak Selected Research
Katrin Sak Research Topics
Disease
53
Neoplasms (Cancer)
12/2023 - 01/2012
9
Carcinogenesis
11/2022 - 01/2016
8
Neoplasm Metastasis (Metastasis)
01/2023 - 01/2015
7
Inflammation (Inflammations)
09/2022 - 01/2018
4
Carcinoma (Carcinomatosis)
09/2022 - 01/2014
4
Prostatic Neoplasms (Prostate Cancer)
04/2020 - 07/2014
3
Lymphoma (Lymphomas)
09/2022 - 08/2018
3
Breast Neoplasms (Breast Cancer)
09/2022 - 01/2017
3
Hematologic Neoplasms (Hematological Malignancy)
08/2018 - 07/2014
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2023 - 09/2022
2
Liver Neoplasms (Liver Cancer)
02/2023 - 02/2018
2
COVID-19
01/2023 - 01/2021
2
Multiple Myeloma
09/2022 - 01/2022
2
Hepatocellular Carcinoma (Hepatoma)
09/2022 - 04/2020
2
Melanoma (Melanoma, Malignant)
01/2022 - 01/2014
2
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019 - 08/2018
2
Leukemia
02/2017 - 01/2015
2
Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2014 - 01/2014
2
Astrocytoma (Pilocytic Astrocytoma)
09/2012 - 07/2005
1
Pain (Aches)
12/2022
Drug/Important Bio-Agent (IBA)
18
Flavonoids
IBA
01/2023 - 01/2014
11
Phytochemicals
IBA
01/2022 - 01/2012
10
Quercetin
IBA
12/2023 - 01/2014
7
Proteins (Proteins, Gene)
FDA Link
01/2023 - 07/2005
6
Antioxidants
IBA
12/2023 - 03/2016
6
Antineoplastic Agents (Antineoplastics)
IBA
01/2023 - 01/2014
5
Polyphenols
IBA
01/2023 - 07/2014
4
Luteolin
IBA
01/2023 - 07/2014
3
STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)
IBA
02/2023 - 01/2022
3
DNA (Deoxyribonucleic Acid)
IBA
01/2023 - 09/2012
3
Curcumin
IBA
01/2023 - 03/2016
3
kaempferol
IBA
01/2022 - 07/2014
3
Apigenin
IBA
01/2022 - 07/2014
3
fisetin
IBA
01/2019 - 09/2016
2
baicalein
IBA
02/2023 - 10/2020
2
Flavones
IBA
02/2023 - 01/2017
2
Genistein
IBA
01/2023 - 01/2019
2
MicroRNAs (MicroRNA)
IBA
01/2023 - 01/2021
2
Silybin (Lagosa)
IBA
01/2023 - 01/2021
2
Lipids
IBA
01/2023 - 01/2020
2
epigallocatechin gallate (epigallocatechin-3-gallate)
IBA
01/2023 - 01/2022
2
Transcription Factors (Transcription Factor)
IBA
09/2022 - 04/2020
2
TOR Serine-Threonine Kinases
IBA
01/2022 - 01/2021
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2022 - 11/2019
2
Hesperidin
IBA
01/2022 - 01/2020
2
Phosphotransferases (Kinase)
IBA
01/2022 - 01/2020
2
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2022 - 11/2019
2
Emodin (Archin)
IBA
01/2022 - 06/2021
2
Mitogen-Activated Protein Kinases
IBA
01/2021 - 11/2019
2
Therapeutic Uses
IBA
01/2021 - 01/2017
2
Vaccines
IBA
01/2021 - 01/2020
2
Matrix Metalloproteinases (MMPs)
IBA
01/2021 - 11/2019
2
3-hydroxyflavone
IBA
02/2018 - 01/2018
2
Biomarkers (Surrogate Marker)
IBA
01/2017 - 01/2016
2
Flavonols
IBA
01/2017 - 09/2016
1
Liposomes (Liposome)
IBA
12/2023
1
Polymers
IBA
12/2023
1
Micelles
IBA
12/2023
1
Gels
IBA
12/2023
1
Gold
IBA
12/2023
1
Lipid Nanoparticles
IBA
12/2023
1
Cyclodextrins
IBA
12/2023
1
Cytokines
IBA
03/2023
1
pembrolizumab
IBA
03/2023
1
Ipilimumab
IBA
03/2023
1
Immune Checkpoint Inhibitors
IBA
03/2023
1
Antibodies
IBA
03/2023
1
Monoclonal Antibodies
IBA
03/2023
1
cemiplimab
IBA
03/2023
1
B7-H1 Antigen
IBA
03/2023
1
atezolizumab
IBA
03/2023
1
baicalin
IBA
02/2023
1
wogonin
IBA
02/2023
1
scutellarin
IBA
02/2023
1
scutellarein
IBA
02/2023
1
ginnalin A
IBA
01/2023
1
Folic Acid (Vitamin M)
FDA Link
Generic
01/2023
1
3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- one
IBA
01/2023
1
Ligands
IBA
01/2023
1
cyanidin
IBA
01/2023
1
Cucurbitacins
IBA
12/2022
1
Phloretin
IBA
12/2022
1
Equol
IBA
11/2022
1
ferulic acid (sodium ferulate)
IBA
11/2022
1
phenolic acid
IBA
11/2022
1
Untranslated RNA (Noncoding RNA)
IBA
09/2022
1
Bortezomib (Velcade)
FDA Link
01/2022
1
Proteasome Inhibitors
IBA
01/2022
1
Cyclin-Dependent Kinase 2
IBA
01/2022
1
Propolis (Bee Bread)
IBA
01/2022
1
ampelopsin
IBA
01/2022
1
ixazomib
IBA
01/2022
1
dutogliptin
IBA
01/2022
1
Gallic Acid
IBA
01/2022
1
galangin
IBA
01/2022
1
dihydromyricetin
IBA
01/2022
Therapy/Procedure
15
Therapeutics
01/2023 - 01/2012
5
Drug Therapy (Chemotherapy)
01/2022 - 01/2012
3
Immunotherapy
01/2022 - 01/2021
3
Radiotherapy
01/2022 - 09/2012